Abstract
Purpose
The goal of this study was to investigate the effects of silencing HIF-1 alpha gene expression with specific small interfering RNA (siRNA) on VEGF production and angiogenesis in epithelial ovarian cancer (EOC) cells.
Methods
Two EOC cell lines, MDAH-2774 and SKOV-3, were cultured under normoxic (20% O2) and hypoxic (2% O2) conditions using standard techniques. After EOC cells were transfected with siRNA, HIF-1 alpha and VEGF mRNA levels were measured by real-time RT–PCR. Angiogenesis was evaluated utilizing an in vitro assay model consisting of human umbilical vein endothelial cells (HUVEC) and polymerized ECM Matrix.
Results
Both EOC cell lines evaluated constitutively expressed HIF-1 alpha and VEGF mRNA. HIF-1 alpha and VEGF mRNA levels were significantly increased in response to hypoxia (P < 0.05). Under hypoxic conditions, inhibition of HIF-1 alpha gene expression by a specific siRNA resulted in a significant reduction in HIF-1 alpha and VEGF mRNA levels (P < 0.05). In the in vitro angiogenesis model, supernatant from the hypoxic EOC cells induced the HUVEC to form a complex tubular network, a hallmark of angiogenesis. Semi-quantitative analysis of the angiogenesis assay revealed a significant reduction in tube formation when supernatant from HIF-1 alpha siRNA-treated hypoxic EOC cell was used (P < 0.05).
Conclusion
Inhibition of HIF-1 alpha expression by specific siRNA resulted in a significant decrease in VEGF production and angiogenesis. Further investigation of HIF-1 alpha inhibition for anti-tumor activity is warranted and may potentially prove HIF-1 alpha as a therapeutic target in the management ovarian cancer.
Similar content being viewed by others
References
Folkman J (2000) Tumor angiogenesis. In: Holland JF (ed) Cancer medicine, 5th edn. BC Decker, Ontario, pp 132–152
Liotta LA, Stetler-Stevenson WG (1991) Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 15(18):5054–5059
Yamamoto S, Konishi I, Mandai M, JKuroda H et al (1997) Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopatholgy and patient survivial, and analysis of serum VEGF levels. Br J Cancer 76:1221–1227
Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249–257
Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M et al (1998) Role of HIF-1alpha in hypoxia-mediated apopotosis, cell proliferation and tumour angiogenesis. Nature 394:485–490
Marxsen JH, Schmitt O, Metzen E, Jelkmann W, Hellwig-Burgel T (2001) Vascular endothelial growth factor gene expression in the human breast cancer cell line MX-1 is controlled by O2 availability in vitro and in vivo. Ann Anat 183:243–249
Semenza GL (2000) HIF-1: using two hands to flip the angiogenic switch. Cancer Metastasis Rev 19:59–65
Wang GL, Jiang B, Rue EA, Semenza GL (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-pas heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:5510–5514
Semenza GL (2002) Signal transduction to hypoxia-inducible factor 1. Biochem Pharm 64:993–998
Zhu G, Saed GM, Deppe G, Diamond M, Munkarah AR (2004) Hypoxia up-regulates the effects of prostaglandin E2 on tumor angiogenesis in ovarian cancer cells. Gynecol Oncol 94:422–426
Munkarah AR, Ali-Fehmi R, Malone J Jr, Deppe G, Saed GM (2006) Knockout of inducible nitric oxide synthase reduces VEGF production and angiogenesis in epithelial ovarian cancer cell lines. Gynecol Oncol 101(Suppl 1):S96
Saed GM, Zhang W, Chegini N, Holmadhal L, Diamond MP (1999) Alteration of type I and III collagen expression in human peritoneal mesothelial cells in response to hypoxia and transforming growth factor-beta. Wound Repair Regen 7:504–510
Saed GM, Diamond M (2002) Hypoxia-induced irreversible up-regulation of type I collagen and transforming growth factor-beta 1 in human peritoneal fibroblasts. Fertil Steril 78:144–147
Wang Y, Minko T (2004) A novel cancer therapy: combined liposomal hypoxia inducible factor 1 alpha antisense oligonucleotides and an anticancer drug. Biochem Pharmacol 68:2031–2042
Jensen RL, Ragel BT, Whang K, Gillespie D (2006) Inhibition of hypoxia inducible factor-1 alpha (HIF-1 alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas. J Neuronocol 78:233–247
Yang G, Cai KQ, Thompson-Lansa JA, Bast RC Jr, Liu J (2004) Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNa against Her-2/neu gene expression. J Biol Chem 279:4339–4345
Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G et al (2003) Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res 63:3403–3412
Milkiewicz M, Ispanovic E, Doyle JL, Haas TL (2006) Regulators of angiogenesis and strategies for their therapeutic manipulation. Int J Biochem Cell Biol 38:333–357
Malone J Jr, Saed GM, Diamond M, Sokol RJ, Munkarah AR (2006) The effects of the inhibition of inducible nitric oxide synthase on angiogenesis of epithelial ovarian cancer. Am J Obstet Gynecol 194:1110–1118
Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D et al (1999) Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases. Cancer Res 59:5830–5835
Parnsare V, Munkarah AR, Schimp Vl, Arabi HM, Saed GM, Morris RT et al (2007) Increased expression of hypoxia-inducible factor 1 α in type I and type II endometrial carcinomas. Mod Pathol 20:35–43
Wang Y, Pakunlu RI, Tsao W, Pozharov V, Minko T (2004) Bimodal effect of hypoxia in cancer: the role of hypoxia inducible factor in apoptosis. Mol Pharm 1:156–165
Salceda S, Caro J (1997) Hypoxia-inducible factor 1 alpha protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced chagnes. J Biol Chem 272:22642–22647
Gartel AL (2006) RNA interference in cancer. Biomol Eng 23:17–34
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Poster presentation at the 38th annual meeting of the Society of Gynecologic Oncologists, San Diego, California, March 2007.
Rights and permissions
About this article
Cite this article
Bryant, C.S., Munkarah, A.R., Kumar, S. et al. Reduction of hypoxia-induced angiogenesis in ovarian cancer cells by inhibition of HIF-1 alpha gene expression. Arch Gynecol Obstet 282, 677–683 (2010). https://doi.org/10.1007/s00404-010-1381-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-010-1381-9